CRTS is pleased to announce that company has appointed MD, PhD, Adjunct Professor of Pharmacology and Drug development Petri Vainio as the CRST’s new Chief Scientific Officer starting from September  2023.
Petri has over 30 years of experience in clinical pharmacology both in academy and in biopharma industry. Before joining CRST, Petri worked as a Senior Medical Officer at Finnish Medicines Agency, Fimea.

Our former Chief Scientific Officer, Professor Emeritus Mika Scheinin will continue to provide his valuable services  to our clients as a Senior Advisor of CRST.

We warmly welcome Petri into the CRST -team and we are eagerly waiting to work with him.